emka & SCIREQ invite you to attend our free virtual panel discussion on September 23rd at 11:00am EST. Experts at the forefront of inhalation toxicology research will discuss Pre-Clinical Models of Smoke Exposure and provide deeper analysis of pre-clinical smoke modelling and the cardiopulmonary outcomes.
Smoking continues to be one of the leading causes of death in the world. With the rise of popularity of Electronic Nicotine Delivery Systems (ENDS) devices, further scientific research is needed to:
- Understand smoke-induced pathophysiological mechanisms
- Develop novel therapeutic agents to treat patients
- Guide the decision-making process for the use of ENDS devices
In addition, the legalization of Cannabis in Canada and various states across the US has created more funding opportunities to understand the pulmonary effects of inhaled cannabis better and improve our understanding of the endocannabinoid system and the potential therapeutic applications.
Following the panel discussion, there will also be a Q&A period to answer any questions from the audience.
Check out the Registration page & full agenda here !